Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lozano

Showing results (261-270 of 284) with videos related to

Pageof 29
Sort By:
Thrombosis and Haemostasis|April 26, 2018
Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune ThrombocytopeniaAlexander T Hardy, Verónica Palma-Barqueros, Stephanie K Watson, et al.
Journal of Personalized Medicine|July 27, 2022
MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial InfarctionAscensión M de Los Reyes-García, José Miguel Rivera-Caravaca, Laura Zapata-Martínez, et al.
JCI Insight|October 10, 2022
Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effectCarlos Bravo-Pérez, Mara Toderici, Joseph E Chambers, et al.
British Journal of Haematology|January 6, 2016
Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutationsJulia Muñoz-Ballester, Tzu H Chen-Liang, Ana M Hurtado, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 14, 2026
miR-146a Mimic Therapy Protects Against Platelet-Mediated ThrombosisSonia Águila, Juan C García-Cañaveras, Laura Zapata-Martínez, et al.
Stem Cells (Dayton, Ohio)|January 15, 2014
Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapyS Navarro, V Moleiro, F J Molina-Estevez, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2023
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disordersAna Zamora-Cánovas, Belén de la Morena-Barrio, Ana Marín-Quilez, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2012
Dual disease resistance mediated by the immune receptor Cf-2 in tomato requires a common virulence target of a fungus and a nematodeJose L Lozano-Torres, Ruud H P Wilbers, Piotr Gawronski, et al.
Haematologica|January 29, 2026
<i>De novo</i> mutations in antithrombin deficiency: high frequency and heterogeneous mechanismsPedro Garrido-Rodríguez, Belén De la Morena-Barrio, Carlos Bravo-Pérez, et al.
Blood Cells, Molecules & Diseases|September 26, 2020
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patientsMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Pageof 29

Showing results (261-270 of 284) with videos related to

Sort By:
Pageof 29
Thrombosis and Haemostasis|April 26, 2018
Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune ThrombocytopeniaAlexander T Hardy, Verónica Palma-Barqueros, Stephanie K Watson, et al.
Journal of Personalized Medicine|July 27, 2022
MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial InfarctionAscensión M de Los Reyes-García, José Miguel Rivera-Caravaca, Laura Zapata-Martínez, et al.
JCI Insight|October 10, 2022
Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effectCarlos Bravo-Pérez, Mara Toderici, Joseph E Chambers, et al.
British Journal of Haematology|January 6, 2016
Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutationsJulia Muñoz-Ballester, Tzu H Chen-Liang, Ana M Hurtado, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 14, 2026
miR-146a Mimic Therapy Protects Against Platelet-Mediated ThrombosisSonia Águila, Juan C García-Cañaveras, Laura Zapata-Martínez, et al.
Stem Cells (Dayton, Ohio)|January 15, 2014
Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapyS Navarro, V Moleiro, F J Molina-Estevez, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2023
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disordersAna Zamora-Cánovas, Belén de la Morena-Barrio, Ana Marín-Quilez, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2012
Dual disease resistance mediated by the immune receptor Cf-2 in tomato requires a common virulence target of a fungus and a nematodeJose L Lozano-Torres, Ruud H P Wilbers, Piotr Gawronski, et al.
Haematologica|January 29, 2026
<i>De novo</i> mutations in antithrombin deficiency: high frequency and heterogeneous mechanismsPedro Garrido-Rodríguez, Belén De la Morena-Barrio, Carlos Bravo-Pérez, et al.
Blood Cells, Molecules & Diseases|September 26, 2020
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patientsMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Pageof 29